About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medical Specialty
Anaesthesia
Bone Diseases
Cardiovascular Medicine
Care of Older People
Cerebrovascular Disorders
Complementary Medicine
Dentistry
Dermatology
Ear, Nose and Throat (ENT) disorders
Emergency Medicine
Endocrinology
Family planning
Gastroenterology
Geriatric Medicine
Haematology
Immunology and vaccination
Infections
Infectious Diseases
Intensive Care (ICU)
Liver disease
Menopause / hormone replacement therapy (HRT)
Mental Health
Neurology
Nutrition and Metabolism
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Pain control
Palliative care
Preventative medicines
Radiology
Renal medicine
Reproductive medicine
Respiratory Medicine
Rheumatology
Sports medicine
Surgery
Travel medicine
Urology
Wound Management
Cancer: bladder
Cancer: brain
Cancer: breast
Cancer: gastroenterological
Cancer: gynaecological
Cancer: haematological
Cancer: kidney
Cancer: lung
Cancer: other
Cancer: pancreas
Cancer: prostate
Cancer: skin
Leukaemia
Lymphoma
Radiotherapy
367 library items
in Cancer: lung
Filter results by:
Date Published
2012 (25)
2011 (57)
2010 (67)
2009 (76)
2008 (52)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Oncology (
remove
)
,
Cancer: lung (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 367
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
1.
NICE draft guidance supports use of erlotinib for first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer
Source:
NICE
,
Date published:
10/05/2012
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: lung
|
Clinical guidelines
|
National Institute of Clinical Excellence (NICE)
NeLM
Area:
News
Press release
Link to draft guidance
2.
Single agent maintenance therapy for advanced stage non-small cell lung cancer: meta-analysis
Source:
Lung Cancer
,
Date published:
10/05/2012
Category:
8.1 Cytotoxic drugs
|
8.2 Drugs affecting the immune response
|
Cancer: lung
NeLM
Area:
News
Abstract
3.
Phase III study finds addition of sunitinib to erlotinib in refractory NSCLC confers no survival advantage
Source:
Journal of Clinical Oncology
,
Date published:
09/05/2012
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: lung
NeLM
Area:
News
Link (abstract)
4.
Launch of NHS national lung cancer campaign
Source:
Royal Pharmaceutical Society
,
Date published:
08/05/2012
Category:
Cancer: lung
|
Department of Health (DH)
|
Information provision
NeLM
Area:
News
Link
Factsheet for pharmacists
Patient leaflet
RPS quick reference guide on lung cancer
Department of Health release
BBC Health report
PSNC press release (added 11.05.12)
5.
Bevacizumab added to carboplatin and paclitaxel does not improve survival in older patients with advanced NSCLC
Source:
JAMA
,
Date published:
18/04/2012
Category:
8.1 Cytotoxic drugs
|
Cancer: lung
NeLM
Area:
News
abstract
6.
Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer – results from the INFORM study
Source:
Lancet Oncology
,
Date published:
17/04/2012
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: lung
NeLM
Area:
News
Abstract
Editorial – subscription required
7.
NICE publishes new quality standards for lung cancer and hip fracture
Source:
NICE
,
Date published:
04/04/2012
Category:
Cancer: lung
|
National Institute of Clinical Excellence (NICE)
|
Rheumatology
NeLM
Area:
News
Lung cancer quality standard
Hip fracture quality standard
8.
Horizon scanning: Two trials evaluating afitinib for lung cancer
Source:
Lancet Oncology
,
Date published:
26/03/2012
Category:
8: Malignant disease and immunosuppression
|
Cancer: lung
|
New drugs
NeLM
Area:
News
Abstract for advanced, metastatic NSCLC (LUX-Lung 1)
Full Access Requires Registration with Lancet Oncology
Abstract for lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2)
Full Access Requires Registration with Lancet Oncology
Editorial
Full Access Requires Registration with Lancet Oncology
9.
Be Clear on Cancer: national campaign to promote earlier diagnosis of lung cancer
Source:
Department of Health
,
Date published:
23/03/2012
Category:
Cancer: lung
|
General practice
|
Information provision
NeLM
Area:
News
Link
10.
Strengths and weaknesses of immunotherapy for advanced non-small-cell lung cancer: meta-analysis
Source:
PLoS One
,
Date published:
16/03/2012
Category:
8.2 Drugs affecting the immune response
|
Cancer: lung
NeLM
Area:
News
Link
Results 1 - 10 of 367
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
